CoreAgeRx Launches Advanced Preventive Longevity Protocols Featuring Microdosing Semaglutide, Microdosing Tirzepatide, and Sermorelin Therapies

Sheridan, WY, USA - August 21, 2026 - As the landscape of health and wellness shifts from reactive treatments to proactive healthspan optimization, CoreAgeRx is proud to announce the launch of its new Preventive Longevity protocols. Designed to support long-term metabolic health, optimal body composition, and cellular rejuvenation, this innovative suite of treatments features Micro Dosing Semaglutide, Micro Dosing Tirzepatide, and Sermorelin therapy.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.